Promoter hypermethylation of SSBP2 was observed in several solid tumors, including gall bladder cancer, esophageal squamous cell carcinoma, prostate cancer, ovarian cancer, and hepatocellular carcinoma [13–15, 20, 22]. Here, SSBP2 is linked to gallbladder cancer.